Skip to content
August 13, 2022

Equity.Guru

Investment information for the new generation

nimodipine

Acasti Pharma (ACST.V) announced today that it has initiated its planned pharmacokinetic (PK) bridging study to evaluate the bioavailability of intravenous (IV) GTX-104 compared to oral nimodipine capsules in…